Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
62 participants
INTERVENTIONAL
2004-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acarbose
Acarbose
100mg, 3 times daily
Exercise
Exercise
Moderate combined exercise, 50 minutes 3 times per week
Exercise + Acarbose
Exercise + Acarbose
See respective monotherapy description
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acarbose
100mg, 3 times daily
Exercise
Moderate combined exercise, 50 minutes 3 times per week
Exercise + Acarbose
See respective monotherapy description
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
45 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Swedish Research Council
OTHER_GOV
Bayer
INDUSTRY
Karolinska Institutet
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suad Efendic, Professor
Role: STUDY_CHAIR
Dpt of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital
Stockholm, Stockholm County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wagner H, Degerblad M, Thorell A, Nygren J, Stahle A, Kuhl J, Brismar TB, Ohrvik J, Efendic S, Bavenholm PN. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes. Diabetes Care. 2006 Jul;29(7):1471-7. doi: 10.2337/dc05-2513.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DNR 03-539
Identifier Type: -
Identifier Source: org_study_id